Associations

Associations

Editas Medicine to Present Groundbreaking Gene Editing Medicine at American Heart Association Scientific Sessions 2025

Editas Medicine, a pioneering gene editing company, will present a digital poster presentation at the upcoming American Heart Association (AHA) Scientific Sessions 2025, showcasing its transformative LDL cholesterol-lowering in vivo CRISPR gene editing medicine. The presentation, titled "A transformative LDL cholesterol-lowering in vivo CRISPR gene editing medicine that functionally